Teva Pharmaceutical Industries (TEVA) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Teva Pharmaceutical Industries (TEVA) is Neutral.

The composite score behind that read is -0.06, weighing +0.33 of bullish evidence against -0.43 bearish.

Teva Pharmaceutical Industries last closed at $41.10, +4.71% on the session.

Against the IVW growth benchmark the position is +3.91% over the forecast window.

The read is built from 15 underlying insights — 3 bullish and 12 bearish.

Agreement across those insights is 80%.

9 graded predictions for TEVA so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Teva Pharmaceutical Industries in the 10th percentile on valuation and the 58th percentile on return on equity, where 100 is best.

Teva Pharmaceutical Industries is classified under Health Care / Pharmaceuticals, with a market capitalisation of $0.

StockMap tracks Teva Pharmaceutical Industries as one of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite Teva Pharmaceutical Industries ranks 74th of 151 in the group, against a group median of -0.08.